Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
24 May 2023
24 May 2023
Historique:
pubmed:
9
6
2023
medline:
9
6
2023
entrez:
9
6
2023
Statut:
epublish
Résumé
The emergence of successive SARS-CoV-2 variants of concern (VOC) during 2020-22, each exhibiting increased epidemic growth relative to earlier circulating variants, has created a need to understand the drivers of such growth. However, both pathogen biology and changing host characteristics - such as varying levels of immunity - can combine to influence replication and transmission of SARS-CoV-2 within and between hosts. Disentangling the role of variant and host in individual-level viral shedding of VOCs is essential to inform COVID-19 planning and response, and interpret past epidemic trends. Using data from a prospective observational cohort study of healthy adult volunteers undergoing weekly occupational health PCR screening, we developed a Bayesian hierarchical model to reconstruct individual-level viral kinetics and estimate how different factors shaped viral dynamics, measured by PCR cycle threshold (Ct) values over time. Jointly accounting for both inter-individual variation in Ct values and complex host characteristics - such as vaccination status, exposure history and age - we found that age and number of prior exposures had a strong influence on peak viral replication. Older individuals and those who had at least five prior antigen exposures to vaccination and/or infection typically had much lower levels of shedding. Moreover, we found evidence of a correlation between the speed of early shedding and duration of incubation period when comparing different VOCs and age groups. Our findings illustrate the value of linking information on participant characteristics, symptom profile and infecting variant with prospective PCR sampling, and the importance of accounting for increasingly complex population exposure landscapes when analysing the viral kinetics of VOCs.
Identifiants
pubmed: 37292842
doi: 10.1101/2023.05.17.23290105
pmc: PMC10246130
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : Arthritis Research UK
ID : FC001159
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001078
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI141534
Pays : United States
Organisme : Arthritis Research UK
ID : FC001030
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/X006751/1
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC011104
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001169
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001099
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001827
Pays : United Kingdom
Références
BMC Med. 2022 Jan 13;20(1):25
pubmed: 35022051
Lancet Infect Dis. 2022 Feb;22(2):183-195
pubmed: 34756186
Lancet. 2022 Apr 23;399(10335):1618-1624
pubmed: 35397851
BMC Med. 2021 Apr 27;19(1):106
pubmed: 33902581
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Nat Biotechnol. 2020 Aug;38(8):927-931
pubmed: 32555528
Nat Med. 2022 Jul;28(7):1491-1500
pubmed: 35395151
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
Science. 2021 Jul 9;373(6551):
pubmed: 34035154
Lancet. 2022 Feb 19;399(10326):715-717
pubmed: 35065005
N Engl J Med. 2021 Dec 23;385(26):2489-2491
pubmed: 34941024
J Med Virol. 2021 Dec;93(12):6794-6797
pubmed: 34264527
Elife. 2022 Nov 16;11:
pubmed: 36383192
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447
Lancet. 2021 Jul 17;398(10296):207-209
pubmed: 34197809
Lancet. 2021 Jun 19;397(10292):2331-2333
pubmed: 34090624
PLoS Biol. 2021 Jul 12;19(7):e3001333
pubmed: 34252080
Nat Med. 2022 May;28(5):1031-1041
pubmed: 35361992
N Engl J Med. 2022 Jul 21;387(3):275-277
pubmed: 35767428
Nat Microbiol. 2021 Jul;6(7):899-909
pubmed: 33907312
Lancet Respir Med. 2022 Nov;10(11):1061-1073
pubmed: 35988572
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748